JP2022531570A5 - - Google Patents
Info
- Publication number
- JP2022531570A5 JP2022531570A5 JP2021564186A JP2021564186A JP2022531570A5 JP 2022531570 A5 JP2022531570 A5 JP 2022531570A5 JP 2021564186 A JP2021564186 A JP 2021564186A JP 2021564186 A JP2021564186 A JP 2021564186A JP 2022531570 A5 JP2022531570 A5 JP 2022531570A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/085209 | 2019-04-30 | ||
| CN2019085209 | 2019-04-30 | ||
| PCT/CN2020/087689 WO2020221277A1 (zh) | 2019-04-30 | 2020-04-29 | 二氨基嘧啶类化合物治疗子宫内膜异位相关的疼痛的方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022531570A JP2022531570A (ja) | 2022-07-07 |
| JP2022531570A5 true JP2022531570A5 (https=) | 2023-05-11 |
| JPWO2020221277A5 JPWO2020221277A5 (https=) | 2023-05-11 |
| JP7663508B2 JP7663508B2 (ja) | 2025-04-16 |
Family
ID=73028778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564186A Active JP7663508B2 (ja) | 2019-04-30 | 2020-04-29 | ジアミノピリミジン化合物を使用することによって、子宮内膜症性疼痛を治療する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12605381B2 (https=) |
| EP (1) | EP3960178B1 (https=) |
| JP (1) | JP7663508B2 (https=) |
| KR (1) | KR102935431B1 (https=) |
| CN (1) | CN114007620B (https=) |
| AU (1) | AU2020266947B2 (https=) |
| BR (1) | BR112021021838A8 (https=) |
| CA (1) | CA3138238A1 (https=) |
| MX (1) | MX2021013347A (https=) |
| SG (1) | SG11202111960PA (https=) |
| TW (1) | TWI737285B (https=) |
| WO (1) | WO2020221277A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7207634B2 (ja) | 2017-11-01 | 2023-01-18 | ベイジン タイド ファーマシューティカル カンパニー リミテッド | Ｐ２ｘ３及び／又はｐ２ｘ２／３受容体アンタゴニスト、それを含む医薬組成物及びその使用 |
| US20250032476A1 (en) * | 2021-11-05 | 2025-01-30 | The Regents Of The University Of California | Alpha-2a adrenergic receptor modulators and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008104474A1 (en) * | 2007-02-28 | 2008-09-04 | F. Hoffmann-La Roche Ag | Diaminopyrimidines |
| MA43821A (fr) * | 2016-03-14 | 2018-11-28 | Afferent Pharmaceuticals Inc | Pyrimidines et variantes de celles-ci, et leurs utilisations |
| MA44489A (fr) | 2016-03-25 | 2019-01-30 | Afferent Pharmaceuticals Inc | Pyrimidines et variants de celles-ci, et leurs utilisations |
| JP7207634B2 (ja) * | 2017-11-01 | 2023-01-18 | ベイジン タイド ファーマシューティカル カンパニー リミテッド | Ｐ２ｘ３及び／又はｐ２ｘ２／３受容体アンタゴニスト、それを含む医薬組成物及びその使用 |
| USD956213S1 (en) | 2020-10-02 | 2022-06-28 | Phillips-Medisize A/S | Autoinjector |
-
2020
- 2020-04-29 SG SG11202111960PA patent/SG11202111960PA/en unknown
- 2020-04-29 US US17/607,475 patent/US12605381B2/en active Active
- 2020-04-29 CA CA3138238A patent/CA3138238A1/en active Pending
- 2020-04-29 KR KR1020217038622A patent/KR102935431B1/ko active Active
- 2020-04-29 EP EP20798599.5A patent/EP3960178B1/en active Active
- 2020-04-29 JP JP2021564186A patent/JP7663508B2/ja active Active
- 2020-04-29 WO PCT/CN2020/087689 patent/WO2020221277A1/zh not_active Ceased
- 2020-04-29 BR BR112021021838A patent/BR112021021838A8/pt unknown
- 2020-04-29 AU AU2020266947A patent/AU2020266947B2/en active Active
- 2020-04-29 MX MX2021013347A patent/MX2021013347A/es unknown
- 2020-04-29 CN CN202080032509.8A patent/CN114007620B/zh active Active
- 2020-04-30 TW TW109114698A patent/TWI737285B/zh active